Identifying the sequence of transmitted strains during acute infection, and defining viral sequence evolution in relation to immune selection pressure, represent critical issues to the development of a successful HIV vaccine. As such, the HIV Sequencing Core will be responsible for the generation of thousands of viral sequences that will require a concerted, organized, and high-throughput approach. To this end we have merged the experience of the Partners AIDS Research Center (PARC) Sequencing Core with the expertise of the Broad Institute (Broad) at the Massachusetts Institute of Technology and Harvard. PARC will manage the collection of samples, isolation of HIV DNA/RNA and initial PCR amplification. Products will then be provided to the Broad for further amplification, sequencing, and data assembly and analysis. Thus, the HIV Sequencing Core is designed to perform full genome viral sequencing on all subjects with primary HIV-1 infection enrolled in this proposal. These data will provide the baseline virology data to select individual study subjects for the proposed specific studies on immunodominance, viral escape, viral fitness, antigen processing, T cell function and T cell receptor usage. Specifically, the HIV Sequencing Core will generate full viral genome sequences at baseline from each of the 600 study subjects, including previously enrolled acute and early infected subjects as well as newly identified acute and early infected subjects. We will also provide follow-up viral sequencing on 150 acute or early untreated subjects at 2, 6, and 12 months of infection. These data will provide a comprehensive analysis of the sequence of transmitted strains as well as viral evolution during untreated HIV infection to enable identifying the rate of viral evolution and specific sites under selection pressure. The Sequencing Core will be responsible for: 1. Characterization of full genome viral sequences at baseline from all 600 acute and early infected subjects and longitudinal time points (2, 6,12 months) post infection in 150 untreated subjects. 2. Automated assembly of sequence data and Inclusion of these data into a database that will enable identification of study subjects for the specific research projects proposed.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-IPG-A (M2))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Massachusetts General Hospital
United States
Zip Code
Scully, Eileen P; Lockhart, Ainsley; Garcia-Beltran, Wilfredo et al. (2016) Innate immune reconstitution with suppression of HIV-1. JCI Insight 1:e85433
Blashill, Aaron J; Tomassilli, Julia; Biello, Katie et al. (2016) Body Dissatisfaction Among Sexual Minority Men: Psychological and Sexual Health Outcomes. Arch Sex Behav 45:1241-7
Carlson, Jonathan M; Du, Victor Y; Pfeifer, Nico et al. (2016) Impact of pre-adapted HIV transmission. Nat Med 22:606-13
Palmer, Christine D; Romero-Tejeda, Marisol; Sirignano, Michael et al. (2016) Naturally Occurring Subclinical Endotoxemia in Humans Alters Adaptive and Innate Immune Functions through Reduced MAPK and Increased STAT1 Phosphorylation. J Immunol 196:668-77
Scully, Eileen; Lockhart, Ainsley; Huang, Lisa et al. (2016) Elevated Levels of Microbial Translocation Markers and CCL2 Among Older HIV-1-Infected Men. J Infect Dis 213:771-5
Sun, Hong; Kim, Dhohyung; Li, Xiaodong et al. (2015) Th1/17 Polarization of CD4 T Cells Supports HIV-1 Persistence during Antiretroviral Therapy. J Virol 89:11284-93
Martins, Mauricio A; Tully, Damien C; Cruz, Michael A et al. (2015) Vaccine-Induced Simian Immunodeficiency Virus-Specific CD8+ T-Cell Responses Focused on a Single Nef Epitope Select for Escape Variants Shortly after Infection. J Virol 89:10802-20
Palmer, Christine D; Tomassilli, Julia; Sirignano, Michael et al. (2014) Enhanced immune activation linked to endotoxemia in HIV-1 seronegative MSM. AIDS 28:2162-6
Vaidya, Sagar A; Korner, Christian; Sirignano, Michael N et al. (2014) Tumor necrosis factor ? is associated with viral control and early disease progression in patients with HIV type 1 infection. J Infect Dis 210:1042-6
Buzon, Maria J; Martin-Gayo, Enrique; Pereyra, Florencia et al. (2014) Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells. J Virol 88:10056-65

Showing the most recent 10 out of 44 publications